Advancing regenerative therapies with wyss zurich
MUVON THERAPEUTICS - 01-Apr-2021Pioneering cell therapy gains momentum with cutting-edge support for clinical trials
Join the club for FREE to access the whole archive and other member benefits.
Wyss Zurich is a joint initiative of the University of Zurich (UZH) and ETH Zurich
Wyss Zurich is a unique accelerator that bridges the gap between cutting-edge research and real-world applications. Established through a generous endowment from Swiss entrepreneur Dr. Hansjörg Wyss, it is a joint initiative between the University of Zurich (UZH) and ETH Zurich, two of the world’s leading academic institutions. The centre focuses on translating discoveries into impactful therapies, medical technologies, and systems in regenerative medicine, robotics, and hybrid fields.
Wyss Zurich fosters interdisciplinary collaboration, assembling experts from diverse fields to tackle some of the most pressing challenges in healthcare and technology. The accelerator supports innovative projects with funding, state-of-the-art facilities, and expertise, empowering teams to move from lab-based research to clinical trials and beyond.
In addition to its scientific mission, Wyss Zurich is committed to fostering sustainability and societal impact, ensuring that its work contributes meaningfully to improving human health and well-being globally.
Visit website: https://www.wysszurich.ch/
Details last updated 02-Dec-2024
Pioneering cell therapy gains momentum with cutting-edge support for clinical trials